New hip stem implant tracked for 10 years in 313 patients

NCT ID NCT05144191

Ongoing Disease control Sponsor: Stryker Orthopaedics Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well the Insignia Hip Stem works and how safe it is for people needing a total hip replacement. It includes 313 adults with conditions like hip arthritis or fractures. Researchers will check implant survival and hip function for up to 10 years after surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AVASCULAR NECROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

avascular necrosis femoral neck fracture hip fracture osteoarthritis osteoarthritis, hip osteonecrosis rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AVASCULAR NECROSIS FEMORAL NECK FRACTURES HIP OSTEOARTHRITIS POST-TRAUMATIC OSTEOARTHRITIS RHEUMATOID ARTHRITIS SURGERY TROCHANTERIC FRACTURES

Contacts and locations

Show contact details

Locations

Alleghany Health Network- Research Institute

Pittsburgh, Pennsylvania, 15212, United States
Baylor Scott and White Medical Center

Temple, Texas, 76508, United States
Midwest Orthopaedics at Rush

Chicago, Illinois, 60612, United States
Northwell Health: University Orthopaedic Associates

Great Neck, New York, 11021, United States
OrthoCarolina Research Institute

Charlotte, North Carolina, 28207, United States
Orthopedic Physician Associates

Seattle, Washington, 98122, United States
Providence Orthopedics and Sports Medicine

Spokane, Washington, 99208, United States
Reno Orthopedic Center Foundation

Reno, Nevada, 89503, United States
TOA Research Foundation

Nashville, Tennessee, 37204, United States
The MORE Foundation

Phoenix, Arizona, 85023, United States
University of California, San Francisco

San Francisco, California, 94158, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.